Clinical Trial Update: Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy trial of dutogliptin/PHX1149T for Type 2 diabetes mellitus has completed. The update notes completion of the pivotal trial, but no r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dutogliptin (dutogliptin)
• PHX1149T (PHX1149T)

Snippet

Sponsor: Phenomix | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED